Zacks Rating on Sanofi (SNY)

Sanofi (SNY) has an average broker rating of 2, which is interpreted as a Buy, as rated by 4 equity analysts. Nonetheless, 2 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 2 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 4, which is also a Sell.

Sanofi (SNY) : Currently there are 2 street experts covering Sanofi (SNY) stock. The most bullish and bearish price target for the stock is $56 and $53 respectively for the short term. The average price target of all the analysts comes to $54.5. The estimated standard deviation from the target is $2.12.


Sanofi has lost 2.13% in the last five trading days and dropped 7.33% in the last 4 weeks. Sanofi has dropped 2.88% during the last 3-month period . Year-to-Date the stock performance stands at -4.59%. Sanofi (NYSE:SNY): On Tuesdays trading session , Opening price of the stock was $38.99 with an intraday high of $39.26. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $38.89. However, the stock managed to close at $39.05, a loss of 0.89% for the day. On the previous day, the stock had closed at $39.4. The total traded volume of the day was 5,765,280 shares.

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products. The emerging markets platform includes products from all three of the Companys principal activities. Under the Companys Pharmaceuticals business, products are grouped into the key fields of diabetes solutions, rare diseases, multiple sclerosis, oncology, thrombosis and cardiovascular disease prevention, nephrology and bio-surgery. The Human Vaccines activity is operated through Sanofi Pasteur. The Animal Health activity is carried out through Merial.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.